Mitochondria:: important target for drug toxicity?

被引：42

作者：

Krähenbühl, S ^{[1
]}

机构：

[1] Univ Basel Hosp, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland

来源：

JOURNAL OF HEPATOLOGY | 2001年 / 34卷 / 02期

关键词：

D O I：

10.1016/S0168-8278(00)00106-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：334 / 336

页数：3

共 25 条

[1] Uncoupling of rat and human mitochondria: A possible explanation for tacrine-induced liver dysfunction [J].

Berson, A ;

Renault, S ;

Letteron, P ;

Robin, MA ;

Fromenty, B ;

Fau, D ;

LeBot, MA ;

Riche, C ;

DurandSchneider, AM ;

Feldmann, G ;

Pessayre, D .

GASTROENTEROLOGY, 1996, 110 (06) :1878-1890

[2] Hepatitis after intravenous buprenorphine misuse in heroin addicts [J].

Berson, A ;

Gervais, A ;

Cazals, D ;

Boyer, N ;

Durand, F ;

Bernuau, J ;

Marcellin, P ;

Degott, C ;

Valla, D ;

Pessayre, D .

JOURNAL OF HEPATOLOGY, 2001, 34 (02) :346-350

[3] Mechanisms for experimental buprenorphine hepatotoxicity:: major role of mitochondrial dysfunction versus metabolic activation [J].

Berson, A ;

Fau, D ;

Fornacciari, R ;

Degove-Goddard, P ;

Sutton, A ;

Descatoire, V ;

Haouzi, D ;

Lettéron, P ;

Moreau, A ;

Feldmann, G ;

Pessayre, D .

JOURNAL OF HEPATOLOGY, 2001, 34 (02) :261-269

[4]

DESCHAMPS D, 1991, J PHARMACOL EXP THER, V259, P894

[5]

DESCHAMPS D, 1994, HEPATOLOGY, V19, P948, DOI 10.1002/hep.1840190422

[6]

FAU D, 1994, J PHARMACOL EXP THER, V269, P954

[7]

FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1371

[8]

FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1377

[9] INHIBITION OF MITOCHONDRIAL BETA-OXIDATION AS A MECHANISM OF HEPATOTOXICITY [J].

FROMENTY, B ;

PESSAYRE, D .

PHARMACOLOGY & THERAPEUTICS, 1995, 67 (01) :101-154

[10] HEPATIC MITOCHONDRIAL-DNA DELETION IN ALCOHOLICS - ASSOCIATION WITH MICROVESICULAR STEATOSIS [J].

FROMENTY, B ;

GRIMBERT, S ;

MANSOURI, A ;

BEAUGRAND, M ;

ERLINGER, S ;

ROTIG, A ;

PESSAYRE, D .

GASTROENTEROLOGY, 1995, 108 (01) :193-200

← 1 2 3 →